Evaluation of the safety and immunogenicity of fractional intradermal COVID-19 vaccines as a booster: A pilot study
Suvimol Niyomnaitham, Somruedee Chatsiricharoenkul, Zheng Quan Toh, Sansnee Senawong, Chatkamol Pheerapanyawaranun, Supaporn Phumiamorn, View ORCID ProfilePaul V Licciardi, View ORCID ProfileKulkanya Chokephaibulkit
doi: https://doi.org/10.1101/2022.07.27.22278116
Suvimol Niyomnaitham
1Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
2Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Somruedee Chatsiricharoenkul
1Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
2Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Zheng Quan Toh
3Murdoch Children’s Research Institute, Parkville, Victoria, Australia
4Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia
Sansnee Senawong
5Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Chatkamol Pheerapanyawaranun
1Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Supaporn Phumiamorn
6Department of Medical Sciences, Ministry of Public Health, Thailand
Paul V Licciardi
3Murdoch Children’s Research Institute, Parkville, Victoria, Australia
4Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia
Kulkanya Chokephaibulkit
1Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
7Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Data Availability
The data presented in this study are available on request from the corresponding author.
Posted July 29, 2022.
Evaluation of the safety and immunogenicity of fractional intradermal COVID-19 vaccines as a booster: A pilot study
Suvimol Niyomnaitham, Somruedee Chatsiricharoenkul, Zheng Quan Toh, Sansnee Senawong, Chatkamol Pheerapanyawaranun, Supaporn Phumiamorn, Paul V Licciardi, Kulkanya Chokephaibulkit
medRxiv 2022.07.27.22278116; doi: https://doi.org/10.1101/2022.07.27.22278116
Evaluation of the safety and immunogenicity of fractional intradermal COVID-19 vaccines as a booster: A pilot study
Suvimol Niyomnaitham, Somruedee Chatsiricharoenkul, Zheng Quan Toh, Sansnee Senawong, Chatkamol Pheerapanyawaranun, Supaporn Phumiamorn, Paul V Licciardi, Kulkanya Chokephaibulkit
medRxiv 2022.07.27.22278116; doi: https://doi.org/10.1101/2022.07.27.22278116
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2300)
- Dermatology (205)
- Emergency Medicine (372)
- Epidemiology (11633)
- Forensic Medicine (10)
- Gastroenterology (685)
- Genetic and Genomic Medicine (3638)
- Geriatric Medicine (342)
- Health Economics (624)
- Health Informatics (2335)
- Health Policy (921)
- Hematology (336)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3393)
- Nursing (193)
- Nutrition (512)
- Oncology (1783)
- Ophthalmology (527)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6031)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (144)